Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 708 (USA) (Dr. Kim)
· consented 2013-12-20
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild DIZZINESS — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE
severe
assessed
2026-08-18
Severe HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-12-31 (study day 12.0); relationship: POSSIBLE
severe
assessed
2026-08-18
Severe STUPOR — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE
severe
assessed
2026-08-18
Severe TRANSIENT ISCHAEMIC ATTACK — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE
mild
assessed
2026-08-18
Mild VISION BLURRED — outcome: RECOVERED/RESOLVED; onset 2014-01-01 (study day 13.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.